- Stocks
- Healthcare
PDEX
Pro-Dex, Inc.
PDEX
NASDAQ·Healthcare·Medical - Instruments & Supplies·Mkt cap $234.4M
$73.41
▲ +18.88%
P/E
22.18
Mkt Cap
$234.4M
52-Wk Range
$23.47–$77.00
52-Week Range
$23.47 - $77.00
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 106.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- 45+ years of specialized expertise in powered surgical instrument design and manufacturing
- Strong relationships with leading medical device OEMs and established market presence
- Proprietary autoclavable technology and multi-function surgical driver platforms
- Integrated consulting services providing regulatory and quality expertise to customers
Bear Case
2 risks
- Low volatility (beta 0.1).
- Premium valuation to Medical Devices peers
Growth
Stable outlook
Rising global demand for minimally invasive surgical procedures and advanced surgical instruments
Value
Premium valuation to Medical Devices peers
Momentum
Strong
+12.9% over 3m
Quality
Stable
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying PDEX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Aug 31, 2026
SEP 3, 2026
Reported EPS of $0.87 vs $0.67 consensus (+29.9% surprise). Revenue of $20.4M vs $19.2M expected (+6.3%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+29.9%
Revenue trend · last 8Q
—
—
+33%
+22%
+16%
+24%
+11%
+17%
Q4 24
Q1 24
Q2 24
Q3 25
Q4 25
Q1 25
Q2 25
Q4 26
$15.0M
$14.9M
$16.8M
$17.4M
$17.5M
$18.5M
$18.7M
$20.4M
Margins · last 8Q
Gross
34.8%
Operating
17.3%
Profit
14.0%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Ascendiant Capital · May 12, 2026
vs Industry
How PDEX stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related